HealthSouth (HLS) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts HLS Hot Sheet
Price: $49.41 --0%
Financial Fact:
Income from discontinued operations, net of tax: -100K
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Income from discontinued operations, net of tax: -100K
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
HealthSouth (NYSE: HLS) reported Q2 EPS of $0.47, $0.11 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $764.4 million versus the consensus estimate of $746.86 million.
For earnings history and earnings-related data on HealthSouth (HLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
